CSF tau and Aβ42 are not useful in the diagnosis of frontotemporal lobar degeneration

Neurology

Volumn 62, Issue 9, 2004, Pages 1649-

  Pijnenburg, Y A L ^a   Schoonenboom, N S M ^a,b   Rosso, S M ^c   Mulder, C ^b   Van Kamp, G J ^b   Van Swieten, J C ^c   Scheltens, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; TAU PROTEIN; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BRAIN DEGENERATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; COMPARATIVE STUDY; DEMENTIA; HOSPITALIZATION; MIDDLE AGED; PREDICTION AND FORECASTING; PSYCHOLOGICAL RATING SCALE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TAU PROTEINS;

EID: 4344580599     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000123014.03499.A7     Document Type: Article

References (6)

1. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
2. Gregory CA, Serra-Mestres J, Hodges JR. Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests? Neuropsychiatry Neuropsychol Behav Neurol 1999;12:128-135.
3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
4. Riemenschneider M, Wagenpfeil S, Diehl J, et al. Tau and Abeta42 protein in CSF of patients with frontotemparal degeneration. Neurology 2002;58:1622-1628.
5. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
6. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58:1615-1621.